Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeparTrio: Response-Guided Neoadjuvant Chemotherapy
NCT00544765Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Sep 2002
- Primary completion
- Feb 2008
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of vinorelbine, capecitabine in breast cancer, sponsored by GBG Forschungs. Started Sep 2002; status: completed.
02
Drugs
vinorelbinecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00544765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544765.